The scientist behind the Lyme disease vaccine with Dr. Richard Marconi | VETgirl Veterinary Continuing Education Podcasts
In this VETgirl online veterinary CE podcast, we interview Dr. Richard T. Marconi. You’re probably wondering why we’re interviewing him, but Dr. Marconi has given numerous Zoetis-sponsored VETgirl podcasts on Lyme disease. The main reason why? To introduce you to the scientist behind the Lyme disease vaccine and all the research!
Dr. Marconi earned his Bachelor of Science degree at William Patterson College and PhD at the University of Montana studying microbiology and biophysical chemistry, respectively. After completing his PhD work, he began his post-doctoral training at the Roche Institute of Molecular Biology where he studied bacterial metabolism. He then accepted an Intramural Research Training Award at the Rocky Mountain Laboratories, an NIH research facility, where he began working on Lyme disease and tick-borne relapsing fever. Dr. Marconi joined VCU Medical Center in 1994 and is now a Full Professor of Medicine. He has 33 years of experience studying pathogenic bacteria including the causative agents of Lyme disease, anaplasmosis, ehrlichiosis, periodontal disease and leptospirosis. He has lectured worldwide, published over 120 research articles, been awarded numerous patents, and has been continuously funded since 1990. He has served on over 100 national and international advisory panels and was a chartered member of the Vaccines for Microbial Diseases NIH Study Section. Dr. Marconi serves on the editorial board for several prestigious journals. In 2016 he received the prestigious Billy R Martin Innovation award for his vaccine work. He is an inventor of VANGUARD®crLYME and is credited for the development of a new vaccine and diagnostic antigen platform called “Chimeritope Technology”. His current research efforts are focused on the development of vaccines and improved diagnostic assays for several bacterial diseases.
This podcast is sponsored by Zoetis, the leading animal health company that develops and markets innovative products such as Vanguard® crLyme, the first and only chimeric recombinant Canine Lyme vaccine. Zoetis is dedicated to supporting its customers and their businesses. Building on more than 60 years of experience in animal health, Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products and genetic tests and supported by a range of services. For more information, visit www.zoetis.com.